Rentschler Biopharma Se
Erwin-Rentschler-Str. 21,
Laupheim, 88471,
Germany
Laupheim, 88471,
Germany
49 73927010
Life Sciences
Rentschler Biopharma Se Technographics
Rentschler Biopharma Se Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Rentschler Biopharma Se and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 840 Rentschler Biopharma Se employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Rentschler Biopharma Se has purchased the following applications: PCS Systemtechnik INTUS 5600 for Time Clock (Hardware) in 2010, Microsoft 365 for Collaboration in 2017, DocuSign eSignature for Digital Signing in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Rentschler Biopharma Se is running and its propensity to invest more and deepen its relationship with PCS Systemtechnik , Microsoft , DocuSign or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Rentschler Biopharma Se revenues, which have grown to $194.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Rentschler Biopharma Se intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Rentschler Biopharma Se Tech Stack and Enterprise Applications
Rentschler Biopharma Se HCM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| PCS Systemtechnik | Legacy | PCS Systemtechnik INTUS 5600 | Time Clock (Hardware) | HCM | n/a | 2010 | 2010 |
In 2010, Rentschler Biopharma Se implemented PCS Systemtechnik INTUS 5600 as part of a Time Clock (Hardware) deployment in Germany to support HR and payroll time recording. The initiative included a PCS DEXICON implementation integrated with SAP, aligning electronic time capture and access control with back end payroll and personnel modules.
The deployment centered on time recording and access control capabilities, modernizing terminal hardware and introducing LEGIC card authentication to standardize clock in and access workflows. Functional emphasis included project based time allocation and centralized employee time capture, with configuration focused on terminal-level enrollment, card management, and time event forwarding to DEXICON for downstream processing.
Integrations were explicit with PCS DEXICON and SAP, creating a chain from terminal event capture through DEXICON processing into SAP HR and payroll modules. Operational coverage is described within Germany and the primary business functions impacted were HR timekeeping, payroll processing, and project time accounting.
PCS reference materials list Rentschler among INTUS customers, and the use of the PCS Systemtechnik INTUS 5600 terminal in the 2010 program is inferred from those product and reference listings rather than documented in a Rentschler case study. The documented changes include LEGIC card adoption and DEXICON to SAP integration, which were intended to improve HR time to payroll accuracy and enable project based time allocation.
|
Rentschler Biopharma Se Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2017 | 2017 |
In 2017, Rentschler Biopharma SE deployed Microsoft 365 as a Collaboration platform to standardize corporate communications and document management across its organization. The Microsoft 365 implementation was positioned to support core business functions including corporate communications, research support services, and administrative teams within the Germany-based operations.
Microsoft 365 was configured to deliver cloud email, real-time team chat, document co-authoring and version control, SharePoint based intranet content management, and the Office productivity suite for authoring and collaboration. Configuration work emphasized content governance, mailbox and file lifecycle controls, and collaboration workflows consistent with Collaboration category best practices.
Public site references indicate Microsoft 365 artifacts are present on the company website, confirming an outward facing footprint as well as internal usage. Governance centered on centralizing access controls and standardizing collaboration policies to align document management and communication workflows across departments.
|
Rentschler Biopharma Se Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| DocuSign | Legacy | DocuSign eSignature | Digital Signing | Content Management | n/a | 2021 | 2021 |
In 2021, Rentschler Biopharma Se implemented DocuSign eSignature as a Digital Signing solution on its corporate website to capture external signatures and formalize website-delivered documents. The deployment positions DocuSign eSignature to handle web-embedded signature capture for customer and partner interactions and to provide a centralized e-signature experience for externally initiated document flows.
The implementation leverages capabilities common to Digital Signing platforms, including embedded signing for browser-based completion, template-driven document workflows, authentication controls for signer verification, and audit trail and envelope management for compliance. DocuSign eSignature is used to standardize signature workflows, create reusable templates, and enforce signing order and validation across website transactions.
Operationally the solution is embedded into the public site to enable external signers to complete agreements and consent forms without requiring separate desktop applications, aligning the application with external contracting and consent capture use cases. The scope described indicates focus on web-based capture and external document execution rather than internal HR or back-office only processes.
Governance for the implementation centers on electronic audit logging, signer authentication policies, and template governance to ensure consistent document structure and legal validity of signatures. DocuSign eSignature supports traceability and record retention features that underpin the website-based signing process and meet standard e-signature compliance expectations.
|
Rentschler Biopharma Se CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Marketing Automation | CRM |
|
2019 | 2019 |
|
Rentschler Biopharma Se TRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Governance, Risk and Compliance | TRM |
|
2020 | 2020 |
|
Rentschler Biopharma Se IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2017 | 2017 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2017 | 2017 |
|
Rentschler Biopharma Se CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Identity and Access Management (IAM) | CyberSecurity |
|
2022 | 2022 |
|
IT Decision Makers and Key Stakeholders at Rentschler Biopharma Se
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Rentschler Biopharma Se Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Rentschler Biopharma Se IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Rentschler Biopharma Se digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Rentschler Biopharma Se Technographics
Rentschler Biopharma Se is a Life Sciences organization based in Germany,
with around 840 employees and annual revenues of $194.0 million.
Rentschler Biopharma Se operates a diverse technology stack with applications such as
PCS Systemtechnik INTUS 5600, Microsoft 365 and DocuSign eSignature,
covering areas like Time Clock (Hardware), Collaboration and Digital Signing.
Rentschler Biopharma Se has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as PCS Systemtechnik, Microsoft and DocuSign.
Rentschler Biopharma Se recently adopted applications including
Microsoft Entra ID (formerly Azure Active Directory) in 2022, DocuSign eSignature in 2021 and Usercentrics Consent Management Platform (CMP) in 2020,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Rentschler Biopharma Se’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Rentschler Biopharma Se’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Rentschler Biopharma Se technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.